Read more about the article Paragonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case

Paragonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case

Device enables donor lungs to safely travel unprecedented distance of 4,788 Miles with a total ischemic time of over 13 hours CAMBRIDGE, MASSACHUSETTS – Feb. 2, 2021 – Paragonix Technologies announces…

Continue ReadingParagonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case
Read more about the article Legacy of Hope Performs First Time Use and Clinical Support of Advanced Preservation Technology for Thoracic and Abdominal Organs

Legacy of Hope Performs First Time Use and Clinical Support of Advanced Preservation Technology for Thoracic and Abdominal Organs

CAMBRIDGE, MASSACHUSETTS – January 11, 2022 – Paragonix Technologies, Inc., a leading provider of donor organ preservation and transport systems, announced the first time, combination use of LIVERguard™ and Paragonix SherpaPak® to…

Continue ReadingLegacy of Hope Performs First Time Use and Clinical Support of Advanced Preservation Technology for Thoracic and Abdominal Organs
Read more about the article Paragonix Technologies Announces Launch of the Paragonix Web Portal, Providing Users Access to Critical Organ Preservation Data

Paragonix Technologies Announces Launch of the Paragonix Web Portal, Providing Users Access to Critical Organ Preservation Data

Real-time, centralized, secure coordination and data for transplant teams to facilitate the optimization of the donation and transplantation process CAMBRIDGE, MASSACHUSETTS – January 4, 2022 – Paragonix Technologies, Inc. is announcing…

Continue ReadingParagonix Technologies Announces Launch of the Paragonix Web Portal, Providing Users Access to Critical Organ Preservation Data
Read more about the article Paragonix Announces First-in-Human use of LIVERguard™ Donor Liver Preservation System by Mayo Clinic

Paragonix Announces First-in-Human use of LIVERguard™ Donor Liver Preservation System by Mayo Clinic

CAMBRIDGE, MASSACHUSETTS – Dec. 15, 2021 –  Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider, announced today the first-in-human clinical use of the only FDA cleared cold storage device…

Continue ReadingParagonix Announces First-in-Human use of LIVERguard™ Donor Liver Preservation System by Mayo Clinic
Read more about the article First-in-Human Use of Investigational NRP-DCD Method Using Paragonix SherpaPak by University of Nebraska Medical Center

First-in-Human Use of Investigational NRP-DCD Method Using Paragonix SherpaPak by University of Nebraska Medical Center

CAMBRIDGE, MASSACHUSETTS – December 1, 2021 – Paragonix Technologies, the leading hypothermic donor organ preservation provider, announced the first-in-human clinical use of the investigational NRP-DCD Method by the University of Nebraska…

Continue ReadingFirst-in-Human Use of Investigational NRP-DCD Method Using Paragonix SherpaPak by University of Nebraska Medical Center
Read more about the article Paragonix Technologies Announces Milestone of 1,000 Preserved Donor Heart Transports

Paragonix Technologies Announces Milestone of 1,000 Preserved Donor Heart Transports

More donor hearts safely traveling long distances with the Paragonix SherpaPak Cardiac Transport SystemCAMBRIDGE, MASSACHUSETTS – November 16, 2021 – Paragonix Technologies, Inc. is announcing a major milestone of 1,000 preserved…

Continue ReadingParagonix Technologies Announces Milestone of 1,000 Preserved Donor Heart Transports